Skip to main content
. 2022 Nov 3;18(6):2141998. doi: 10.1080/21645515.2022.2141998

Table 3.

Pediatric vaccine co-administration HV with PCV13 and RV1in 5 LHAs in Sicily from 2016–2019. (Note: during 2018 and 2019 both HV vaccines were used, coadministration data are reported independently whit HV administered).

LHA Year Co-administration with PCV 13 vaccine by dose (%)
Co-administration with RV1 vaccine by dose (%)
1st dose 2nd dose 3rd dose 1st dose 2nd dose
AG 2016 96.3 96.4 92.7 70.8 72
2017 97.7 93.3 86.8 77 76.5
2018 95.0 94.9 93.6 79.5 78.9
2019 92,6 92,3 90,7 80.6 78.8
CT 2016 90.2 89.1 88.6 38.4 37.1
2017 91.5 90.6 89.7 41.4 40.3
2018 92.1 91.5 90.2 51.7 50.2
2019 92.0 90.6 88.7 52.2 51.2
PA 2016 95.3 96.2 97,1 72.2 71
2017 96.2 98.5 99.1 65.2 66
2018 98.5 99.3 99.6 68.5 65.3
2019 97.7 99.3 99.4 67.2 64.2
RG 2016 91.7 90.2 91 51.9 50.5
2017 98 97 95 51.2 50
2018 90.1 92.0 89.0 53.1 52.1
2019 89.1 89.2 90.3 66.2 64.6
TP 2016 98 97 91 79.1 76.3
2017 99 98.6 95.2 76.7 75.8
2018 98.2 97.6 94.3 80.3 78.2
2019 98.6 93 89.8 82.1 80.2